Cover Story
Guest Editorial
As the world faced the threat of a novel respiratory pathogen, SARS-CoV-2, in the first months of 2020, there was a great deal of uncertainty about its effect on people, especially those living with a diagnosis of cancer.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.” - Art exhibit at University of Miami Sylvester bridges North and South America
- Don’t confirm RFK Jr. for HHS, 77 Nobel laureates urge the Senate
- The Human Tumor Atlas Network charts the roadmap for advancing spatial omics
- VCU awarded $9M from NCI to establish Cancer Control Equity Research Center
- The Cancer Letter’s most-read stories of 2024